According to foreign reports, recently, e-alternative solutions (EAS), a US e-cigarette company, has received the acceptance and filing letter from the US Food and Drug Administration (FDA) on its leap and leap go products.
EAS is currently in the substantive review stage of the pre marketing tobacco product application (PMTA) process. If successful, this phase will result in FDA sales orders authorizing the continued sale and sale of these products.
Chris Howard, vice president, general counsel and Chief Compliance Officer of EAS, said: “the substantive review is the result of our efforts over several months to collect more than 100000 pages of evidence, which supports our claim that leap and leap go products are suitable for protecting public health.”.
“We look forward to continuing to work with (the food and Drug Administration) in the coming weeks and months and remain optimistic that the PMTA process will generate market orders.”